Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 47 Results Clear All
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease
How do brain cells change with age? How are liver cells impacted when someone takes a new medicine? What happens to lung cells after decades of smoking?
AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS
Scientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
Gladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
SLAS—Steve Finkbeiner, director of the Center for Systems and Therapeutics, was selected as the recipient of the 2026 Innovation Award by the Society for Laboratory Automation and Screening for his work on AI, robotics, and the thinking microscope.
Gladstone Experts Finkbeiner Lab AI Robotic Microscopy
The Washington Post—As the National Institutes of Health announced it would no longer support research that utilizes fetal tissue, Gladstone Investigator Steve Finkbeiner explains the importance of using this model to better understand Alzheimer’s disease. (Subscription required.)
Gladstone Experts Finkbeiner Lab
Nature—Gladstone Investigator Steve Finkbeiner comments on new restrictions that many scientists believe will slow research on fetal development and stem-cell biology.
Gladstone Experts Finkbeiner Lab
The AI Journal—A collaboration between Topos Bio and the team led by Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, aims to apply a new approach to neurodegenerative disease.
Gladstone Experts Alzheimer’s Disease Neurological Disease Finkbeiner Lab
Shijie Wang, a postdoctoral scholar in Steve Finkbeiner’s lab, uses artificial intelligence, robotics, and stem cell technologies to uncover how brain cells die in neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Profile Neurological Disease Finkbeiner Lab AI Robotic Microscopy
In this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data
The New York Times—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, notes that a new gene therapy shows promise for patients affected by Huntington’s disease, but untreated brain regions may still experience neurodegeneration. (Subscription required.)
Gladstone Experts Huntington’s Disease Neurological Disease Center for Systems and Therapeutics Finkbeiner Lab
ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab
Research Associate Christina Buselli describes her work in the Finkbeiner lab, her path to science, and the questions she wishes she could ask her grandfather
Profile Finkbeiner Lab
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab
Global News Wire—Gladstone Investigator Steve Finkbeiner was awarded the 2022 Leslie Gehry Prize for Innovation in Science. The award recognizes his advancements in developing novel technologies, such as robotic microscopy and deep learning pipelines, that can be used to understand and develop treatments for Huntington’s disease.
Gladstone Experts Huntington’s Disease Center for Systems and Therapeutics Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab Robotic Microscopy
